360 related articles for article (PubMed ID: 7810648)
1. Inhibition of ornithine decarboxylase does not prevent intestinal smooth muscle hyperplasia in the rat.
Luck MS; Bass P
Am J Physiol; 1994 Dec; 267(6 Pt 1):G1021-7. PubMed ID: 7810648
[TBL] [Abstract][Full Text] [Related]
2. Role of polyamines in the early adaptive response to jejunectomy in the rat: effect of DFMO on the ileal villus:crypt axis.
Bamba T; Vaja S; Murphy GM; Dowling RH
Digestion; 1990; 46 Suppl 2():410-23. PubMed ID: 2124563
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of polyamine formation antagonizes vascular smooth muscle cell proliferation and preserves the contractile phenotype.
Grossi M; Persson L; Swärd K; Turczyńska KM; Forte A; Hellstrand P; Nilsson BO
Basic Clin Pharmacol Toxicol; 2014 Nov; 115(5):379-88. PubMed ID: 24666424
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of proximal small intestinal mucosal growth by luminal polyamines.
Wang JY; McCormack SA; Viar MJ; Johnson LR
Am J Physiol; 1991 Sep; 261(3 Pt 1):G504-11. PubMed ID: 1716059
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of increases in ornithine decarboxylase and putrescine has no effect on rat liver regeneration.
Beyer HS; Ellefson M; Stanley M; Zieve L
Am J Physiol; 1992 Apr; 262(4 Pt 1):G677-84. PubMed ID: 1566849
[TBL] [Abstract][Full Text] [Related]
6. Induction of ornithine decarboxylase activity and putrescine synthesis in arterial smooth muscle cells stimulated with platelet-derived growth factor.
Thyberg J; Fredholm BB
Exp Cell Res; 1987 May; 170(1):160-9. PubMed ID: 3106075
[TBL] [Abstract][Full Text] [Related]
7. Renal ornithine decarboxylase activity, polyamines, and compensatory renal hypertrophy in the rat.
Humphreys MH; Etheredge SB; Lin SY; Ribstein J; Marton LJ
Am J Physiol; 1988 Aug; 255(2 Pt 2):F270-7. PubMed ID: 3136663
[TBL] [Abstract][Full Text] [Related]
8. Ornithine decarboxylase and polyamines in tissues of the neonatal rat: effects of alpha-difluoromethylornithine, a specific, irreversible inhibitor of ornithine decarboxylase.
Slotkin TA; Seidler FJ; Trepanier PA; Whitmore WL; Lerea L; Barnes GA; Weigel SJ; Bartolome J
J Pharmacol Exp Ther; 1982 Sep; 222(3):741-5. PubMed ID: 6809932
[TBL] [Abstract][Full Text] [Related]
9. Polyamines in pancreatic growth.
Fölsch UR; Löser C; Alves F
Digestion; 1990; 46 Suppl 2():345-51. PubMed ID: 2262066
[TBL] [Abstract][Full Text] [Related]
10. Polyamine content of Pneumocystis carinii and response to the ornithine decarboxylase inhibitor DL-alpha-difluoromethylornithine.
Merali S; Clarkson AB
Antimicrob Agents Chemother; 1996 Apr; 40(4):973-8. PubMed ID: 8849262
[TBL] [Abstract][Full Text] [Related]
11. Polyamines and intestinal epithelial hyperplasia in streptozotocin-diabetic rats.
Younoszai MK; Parekh VV; Hoffman JL
Proc Soc Exp Biol Med; 1993 Feb; 202(2):206-11. PubMed ID: 8424111
[TBL] [Abstract][Full Text] [Related]
12. Luminal polyamines substitute for tissue polyamines in duodenal mucosal repair after stress in rats.
Wang JY; Johnson LR
Gastroenterology; 1992 Apr; 102(4 Pt 1):1109-17. PubMed ID: 1551519
[TBL] [Abstract][Full Text] [Related]
13. Relationship between heat sensitivity and polyamine levels after treatment with alpha-difluoromethylornithine (DFMO).
Mivechi NF; Dewey WC; Feuerstein BG; Deen DF; Marton LJ
Radiat Res; 1986 Dec; 108(3):269-81. PubMed ID: 3099327
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of ornithine decarboxylase activity decreases polyamines and suppresses DNA synthesis in human colonic lamina propria lymphocytes.
Elitsur Y; Strom J; Luk GD
Immunopharmacology; 1993; 25(3):253-60. PubMed ID: 8354641
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Polyamine Uptake Potentiates the Anti-Proliferative Effect of Polyamine Synthesis Inhibition and Preserves the Contractile Phenotype of Vascular Smooth Muscle Cells.
Grossi M; Phanstiel O; Rippe C; Swärd K; Alajbegovic A; Albinsson S; Forte A; Persson L; Hellstrand P; Nilsson BO
J Cell Physiol; 2016 Jun; 231(6):1334-42. PubMed ID: 26529275
[TBL] [Abstract][Full Text] [Related]
16. Effects of starvation and difluoromethylornithine (DFMO) on diamine oxidase activity in rat ileum.
Erdman SH
Digestion; 1990; 46 Suppl 2():396-402. PubMed ID: 2124561
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of ileal and colonic ornithine decarboxylase activity by alpha-difluoromethylornithine in rats: transient atrophic changes and loss of postresectional adaptive growth.
Kingsnorth AN; Abu-Khalaf M; LaMuraglia GM; McCann PP; Diekema KA; Ross JS; Malt RA
Surgery; 1986 Jun; 99(6):721-7. PubMed ID: 2424111
[TBL] [Abstract][Full Text] [Related]
18. Mucosal ornithine decarboxylase, polyamines, and hyperplasia in infected intestine.
Wang JY; Johnson LR; Tsai YH; Castro GA
Am J Physiol; 1991 Jan; 260(1 Pt 1):G45-51. PubMed ID: 1846274
[TBL] [Abstract][Full Text] [Related]
19. Importance of various intracellular regulatory mechanisms of polyamine metabolism in camostate-induced pancreatic growth in rats.
Löser C; Fölsch UR
Digestion; 1993; 54(4):213-23. PubMed ID: 8243835
[TBL] [Abstract][Full Text] [Related]
20. Tumor angiogenesis and polyamines: alpha-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, inhibits B16 melanoma-induced angiogenesis in ovo and the proliferation of vascular endothelial cells in vitro.
Takigawa M; Enomoto M; Nishida Y; Pan HO; Kinoshita A; Suzuki F
Cancer Res; 1990 Jul; 50(13):4131-8. PubMed ID: 1693880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
